AR046205A1 - Formulacion farmaceutica de licofelona - Google Patents

Formulacion farmaceutica de licofelona

Info

Publication number
AR046205A1
AR046205A1 ARP040103905A ARP040103905A AR046205A1 AR 046205 A1 AR046205 A1 AR 046205A1 AR P040103905 A ARP040103905 A AR P040103905A AR P040103905 A ARP040103905 A AR P040103905A AR 046205 A1 AR046205 A1 AR 046205A1
Authority
AR
Argentina
Prior art keywords
water soluble
pharmaceutical formulation
copolymers
soluble polymer
licofelona
Prior art date
Application number
ARP040103905A
Other languages
English (en)
Inventor
F Sievert
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of AR046205A1 publication Critical patent/AR046205A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulación farmacéutica sólida que comprende licofelona o una sal farmacéuticamente aceptable de la misma y por lo menos un polímero soluble en agua seleccionado entre hidroxialquil celulosa, metil celulosa, polivinil pirrolidonas y copolímeros de los mismos, alcoholes polivinílicos, copolímeros hidrolizados o parcialmente hidrolizados de N-vinilpirrolidona y ésteres vinílicos, y/o por lo menos un poliol soluble en agua seleccionado entre polietilen glicoles con un peso molecular que oscila entre 8000 y 20000 y alcoholes de azúcares. La formulación libera con rapidez el ingrediente activo. Uso de un polímero soluble en agua y/o un poliol soluble en agua para producir dicha formulación farmacéutica.
ARP040103905A 2003-10-31 2004-10-27 Formulacion farmaceutica de licofelona AR046205A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10351035A DE10351035A1 (de) 2003-10-31 2003-10-31 Pharmazeutische Licofelone-Formulierung

Publications (1)

Publication Number Publication Date
AR046205A1 true AR046205A1 (es) 2005-11-30

Family

ID=34485181

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103905A AR046205A1 (es) 2003-10-31 2004-10-27 Formulacion farmaceutica de licofelona

Country Status (4)

Country Link
AR (1) AR046205A1 (es)
DE (1) DE10351035A1 (es)
TW (1) TW200524592A (es)
WO (1) WO2005041920A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109718220A (zh) * 2017-10-27 2019-05-07 天津药物研究院有限公司 Ml-4000包合物胶囊的制备方法
EP3593792A1 (de) 2018-07-11 2020-01-15 Welding GmbH & Co. KG Pharmazeutische zusammensetzung umfassend 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäurecholinsalz
WO2023089636A1 (en) * 2021-11-21 2023-05-25 Aizant Drug Research Solutions Private Limited Pharmaceutical compositions of licofelone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136839A (en) * 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
DE69709069T2 (de) * 1996-02-13 2002-07-04 Searle & Co Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
DE10121252A1 (de) * 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
EP1505964B1 (en) * 2002-05-17 2007-11-21 Merckle Gmbh Annelated pyrrole compounds as proton pump inhibitors for treating ulcer

Also Published As

Publication number Publication date
DE10351035A1 (de) 2005-05-25
WO2005041920A2 (de) 2005-05-12
WO2005041920A3 (de) 2005-07-14
TW200524592A (en) 2005-08-01

Similar Documents

Publication Publication Date Title
CO5261563A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
PE20061160A1 (es) Sistema de administracion de farmacos con retencion gastrica
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
PE20040131A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
CY1116023T1 (el) Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
ATE515949T1 (de) Süssware
ME00482B (me) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
AR069552A1 (es) Formulaciones para el tratamiento de semillas y metodos de uso
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
NO974194D0 (no) Forbedringer i, eller vedrörende, organiske sammensetninger
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ES2111547T3 (es) Comprimido de liberacion prolongada.
AR018862A1 (es) Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
ATE347805T1 (de) Gegen verfärbung beständige aerosolsprays
DE602004003577D1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
BR0112847A (pt) Uso de uma forma de dosagem sólida

Legal Events

Date Code Title Description
FB Suspension of granting procedure